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Background: Medicinal chemistry traditionally requires ranging from 10 p,M to < 1 PM in the dopamine and sero- 
the identification of biologically active molecules by syn- tonin reuptake systems. The conformation of one of these 
thesizing and screening each purified substrate. Further 
progress in drug discovery then requires definition of the 
tripeptides, N-acety-I)-Trp-L-Phe-r)-Lys-CONHz (which 
structure~actlvl~ relationship of the lead compound. 
inhibits serotonin uptake with an ICs,, of 10 PM) was com- 
More recently, combinatorial chemistry has emerged as a 
pared to that of the serotonin uptake inhibitor s-fluoxetine, 
and was shown to be more similar in conformation to 
way to esamme structure-activity relationships by screen- fluoxetine than was an analogous tripeptlde containing 
ing a large mixture of compounds synthesized in a pre- 
dictably random manner, without the labor-intensive costs 
L-Lys (X5,, > 50 FM). 
Conclusions: We have identified five tripeptides with 
of molecular isolation and purification. We set out to LIW 
this approach to examine the structural requirements for 
inhlbltory IC5,, values of < 10 PM in the serotonin reup- 
take system. One tripeptide was predicted to have 
peptide binding to serotonin and dopamine transporters. pharrnacophore features similar to that of fluoxetine, a 
Results: We screened a tripeptide cassette library for serc>- selective and potent non-peptide serotonin reuptake 
tonin and dopamine reuptake inhibition using cloned trans- inhibitor. Our results suggest that tripeptides derived from 
porter assay 5ystems.The method has afforded a number of combinatorial libraries will help to define the important 
tripeptide pharmacophores with inhibitory IC,,, values structural elements of pharmacophores. 
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Introduction 
Combinatorial molecular libraries have been used to 
allow the screening of large numbers of compounds 
without the cumbersome and time-consuming require- 
ment of isolating and purifying each substituent [l]. 
Solid-phase synthesis of a predictable pattern of a 
mixture of peptides, followed by cleavage to the free 
peptides, could, in theory, be used in screening for func- 
tional and/or binding activity in enzyme and receptor 
systems. Our strategy was to assemble a 10 000 com- 
pound tripeptide cassette library via solid-phase synthesis 
and to investigate: (1) the ability to identify inhibitors of 
serotonin and dopamine cotransporter proteins that are 
active in the pmolar range from this library, and (2) the 
utility of a tripeptide inhibitor(s) as a ‘molecular tem- 
plate for identifying the important structural features of 
known serotonin non-peptide reuptake inhibitors [2-41. 
Results and discussion 
We selected 22 different amino acids, using both the 13 and 
I. configurations, to construct the peptide library (Table 1). 
E,tch protected amino acid was separately bound to resin 
through a standard solid-phase peptide-synthesis protocol. 
The individual resin-bound amino acids were physically 
mixed to form an equimolar mixture of the 22 various 
amino acids.This mixture was subsequently redivided into 
22 portions (each containing the equimolar ratio of the 22 
amino acids). A second coupling of all protected amino 
Table 1. Amino acids used to construct the peptide library. 
D-Ala 
L-Arg 
o-Asn 
~-Asp 
L-Gin 
D-an 
L-His 
L-lie 
D-Leu 
L-Lys 
o-Lys 
L-Met 
L-Phe 
D-Phe 
L-Pro 
D-h0 
L-Ser 
L-Trp 
D-Trp 
i-Tyr 
o-Tyr 
L-Val 
*Corresponding authors. 
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X,.=-resin (N-terminal mixture) 
t 
Y,.z-C02H 
ywz-x,.,-resin (mixture of 484 peptide-resins) 
ZVCO~H z...wcO,H 
T 
Z&OzH z...P-y~-22-x,,-resin 
(mixture of 484) 
z1-ywz-x,~~-resin Zz-YI-22-x,,-resin 
(mixture of 484) (mixture of 484) 
10,848 peptide-resins 
t 
1) N-acetylation 
2) HF Cleavage 
CH,-CONH-Z-Y-X-CONH~ 
Fig. 1. Scheme for constructing a combinatorial peptide library. 
Each of the 22 amino acids shown in Table 1 was separately bound 
to resin, then all 22 were mixed in an equimolar ratio (X,,,-resin). 
The mixture was divided into 22 aliquots, and a second coupling 
reaction was performed, again using all 22 amino acids, resulting 
in a mixture of all possible dipeptides (484 in all) coupled to the 
resin (Y,_**-X,~,,-resin).The mixture was split again, and the third 
coupling reaction was performed, followed by N-acetylation and 
cleavage without mixing. This results in 22 mixtures of 484 tripep- 
tides, in each of which the amino-terminal amino acid (Z,) is 
known while the other two are not. 
acids was performed on the mixtures and these were again 
mixed and redivided.The final coupling was done on all 
of the resin-bound dipeptide mixtures with all of the 22 
protected amino acids.The identity of the final protected 
amino acid in each reaction vessel was noted so that after 
amino-terminal capping with acetic anhydride, followed 
by cleavage from the resin to form the carboxy-terminal 
amide, the first preparation of the 22 separate mixtures 
yielded a schematic generic structure depicted as: acety- 
amino acid]-[unknown amino acid(,-,, ]- 
amino carboxanlideC,P,,j] (Fig. 1). MO el d 
Fig. 2. Inhibition of the uptake of tritiated serotonin by first-round 
library pools. The histogram shows the percent inhibition of the 
uptake of serotonin into rat basophil leukemia (RBL) cells by a 
SO0 nM concentration of peptides from the pools identified by 
their amino-terminal amino acid. First letter lower case denotes 
the D amino acid; upper case denotes the L amino acid. 
(a) 
ho’:,, 
50% 
125 nMcr,nr. 
40% 
30% 
2 0% 
1 0% 
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(b) 
Fig. 3. Comparison of dose dependence of inhibition of serotonin 
uptake with inhibition of dopamine uptake for four peptide pools. 
(a) Inhibition of serotonin uptake. (b) Inhibition of dopamine 
uptake. First letter lower case denotes the 13 amino acid; upper 
case denotes the I. amino acid. 
peptides made using this process gave good amino-acid 
analysis (see 111). 
The first round of screening in both the dopamine and 
serotonin reuptake assays afforded a number of known- 
p&q-22) tripeptides with comparable activity at 
concentrations (Fig. 2) [S,h].We next examined 
the dose response for selected tripeptide pools with both 
the serotonin and dopamine reuptake assays, using doses 
ranging from 8 nM to 500 nM and from 5 PM to 
500 PM, respectively (Fig. 3). Relative inhibitory activity 
in both assays was comparable (compare Fig. 3a with Fig. 
3b), and we therefore selected r)-Trp for the amino-term- 
inal position, that is, Z = I)-Trp for the continued itera- 
tive processes. For the second iteration, tripeptide 
mixtures of the form: acetyL,-Trp-[known amino acid]- 
Xc,+,,) were used (Fig. 4). The activity of the acety-I)- I- 
Lys-[known amino acid]-XC,-22j was comparable to the 
acety-I,-Trp-[known amino acid]-XCIP,,) mixture up to 
this iteration and is shown in Figure 4a. The tripeptide 
mixture, acety-l)-Trp-L-Phe-XC1~22j appeared to have the 
best overall activity in assays of dopamine (Fig. 4a) and 
serotonin (Fig. 4b) reuptake inhibition, and this mixture 
was therefore used for the final iteration, the synthesis of 
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(a) 
100 “ia 
Fig. 4. Inhibition of dopamine and serotonin uptake by tripeptid e 
pure tripeptides. A second reason for choosing this 
peptide mixture was the prediction (by M.C.) that acetyl- 
I)-Trp-L-Phe-Lys-CONH, would show good fit to 
s-fluoxetine (see below). - 
We synthesized 22 tripeptides derived from the f?unily of 
mixtures N-acetyl-I,-Trp-L-Phe-X-CONH? and nine 
tripeptides with an unacetylated amino terminus, and 
evaluated their individual activities in the assay systems 
181. Tripeptides having the carboxy-terminal II-Tyr and 
I)-Trp had IC,,, values of 3.2 PM and 3.5 PM, respec- 
tively, in the cerotonin reuptake aTsay (Fig. 5). Most 
importantly, the cnrboxy-terminal I)-Lys peptide, marked 
as 111 in Figure 5, had an IC,,, of 10.0 p,M, whereas the 
corresponding I -Lys peptide, marked as [II] in Figure 5, 
was inactive, with an 1C5,, > 30 FM. Moreover, the free 
NH,, amiilo-terniiIlus derivative of the carboxy-terminal 
II-L>;< peptide, [III], had an ICs,, of 5.3 PM in the sero- 
tonin reuptake assay and an ICJ,, < 1 FM in the 
dopnmine reuptake assay. 
At this stage of our investigation, \ve were intrigued by 
the idea of using peptide combinatorial libraries to iden- 
tify three-dimensional structural features of successful 
neurotrnnsmitter reuptake inhibitors, using the struc- 
ture-activity relationship5 of selected known inhibitors 
and peptides selected from our libraries. To test this 
approach, comparisons were made between the active 
tripeptides md fluosetine, a potent serotonin reuptake 
inhibitor, using molecular modeling methods. The 
Cartesian forcing algorithm within the molecular Gnli- 
larity module of QUANTA/CHAKMm. Version 4.0, 
pools in which the amino-terminal two amino acid residues are 
identified. (a) DWe dependence of inhibition of dopamine uptake 
was used to determine the degree of beht-fit between 
by selected tripeptides of the form Ac-D-Trp-[known amino acid]- s-tluoxetine and each of the two library tripeptides, 
unknown llmII,-CONHL and Ac-L-Lys-[known amino acid]- ,lcet~l-1)-T1-p-~-l’lle-1 -Ly+amide. [I], and acetyl-I)-Trp- 
unknowqmJl,- CONH,. Mixtures were selected on the basis of I)-l’he-I)-Lys-3inide, [ 1 I], which dif&r only in stereo- 
dopamine and serotonin inhibition. Concentrations used: blue, 
I .I FM; red, 3.i FM ; green, 10 FM. (b) Inhibition of serotonin 
chemistry at the Lys position. Setup parameters used in 
uptake by tripeptides of of the form Ac-D-Trp-(known amino 
these calculations were a 1 J A non-bonded cutoff dis- 
<a( id-unknown ,1-J? XONH, at a concentration of 500 nM. tarice, d root-mean square force of 0.01 kcal mole-’ A-’ 
Compound IC,, WW 
N ti+Trp-1 -Pht-n-Tyr-CONH? 3.2 
Ac-NH-n-Trp-I-Phe-D-Trp-CONH, ‘I.5 
NH1-l)-TrF,-L-Phe-l)-Lys-CONHI 11111 5.3 
NH ,-I)-Trt,-L-Phe-t~His-CONH, 8.9 
NH$Trp -Phe-L-Arg-CONH, 8.9 
Ac-NH-n-Trp~l-Phe-D-Lys-CONHL III 10.0 
AC-NH-D-Trp-I-Phe-L-Trp-CONH, 11.2 
Ac-NH-n-Trp-1 -Phe-i-Tyr-CONH, 12.6 
Ac-NH-I,-Trp-L-Phe-~,-Tyr-coNH~ 14.0 
NH+-Trp-I -Phcl-i-Ser-CONH, 14.1 
Ac-NH-r)-Trp-I~-Phe-D-Vat-CONH, 17.8 
Ac-NH-n-Trp-1 -Phe-L-Phe-CONHi 25.0 
Ac-NH-I)-Trp-L-Phe-t-I-eu-CONH? 2.5.1 
Ac-NH-l,-Trp-l~-Phe-l,-Phe-CONHL 28.2 
Ac -NH-r,-Trp-1 -Phc-n-Pro-CONH, 31.6 
Compounds with IC,, 150 FM 
A~-NH-D-Trp-L-Phe-n-Ala-CONH, 
Ac-NH-o-Trp-L-Phe+Pro-CONHJ 
A~-NH-D-T~~-L-P~~-L-S~~-CONH, 
Ac-NH-o-Trp-L-Phe-D-(;ln-CONH, 
Ac-NH-r,-Trp-L-Phe-L-Asp-CONHi 
Ac-NH-r)-Trp-L-Phe-L-Arg-CONH:, 
Ac-NH-I)-Trp-L-Phe-i-His-CONHL 
Ac-NH-D-Trp-1 -Phe-L-Gin-CONH, 
Ac-NH-D-Trp-L-Phe-v-Asn-CONHI 
Ac-NH-u-Trp-1 -Phe-L-lie-CONH, 
AL-NH-D-Trp-L-Phe-1 -Met-CONH? 
Ac-NH-I)-Trp-L-Phe-l-Lys-CONH? [II] 
NH,-D-T~~-L-P~~-~)-GI~-(~ONH, 
NH,-n-Trp-i-Phe-L-Asp-CONHL 
NH,-r)-Trp-L-Phe-L-Gin-CONHI 
NH,-r,-Trp-L-Phe-r,-Asn-(_OI\JH, 
Fig. 5. Inhibition of scrotonin reuptake by single tripeptides. The activity of fluoxetine i> -5 nM. The compound NH,-o-Trp-l-Phe~l)-Lys-CONHL 
\~a5 the only one to have notable activity in the dopamine inhibition assay (IC,,, cl PM). All others were ineffcctlve at 50 ~~‘vt. 
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Fig. 6. Minimum energy conformation of s-fluoxetine. The con- 
formation of the propylamine side chain is observed to be sta- 
bilized by an intramolecular hydrogen bond (2.1 A) between the 
amine nitrogen and phenoxy oxygen atoms. Hydrophobic and 
positive ionizable regions that define the ligand pharmacophore 
are indicated. 
and 0.001 energy tolerance for determining minimiza- 
tion convergence, and dielectric Constance of 4.0, since 
discrete waters were not included. The global low energy 
H’ 
NH: 
(D)-Trp-it)-Phe-(D.L)-Lys ” 
AE R&X RMS fit IC,, 
(Kcal molF) (A) (pM) 
Ac-NH-o-Trp-L-Phe-o-Lys-CONH, -10.4 2.1 5.3 
Ac-NH-o-Trp-L-Phe-L-Lys-CONH: >104 2.3 >50 
Fig. 7. Cartesian fit of D-Trp-L-Phe-o,L-Lys to s-fluoxetine. 
Equivalent atoms on different molecules, which were forced to 
occupy the same space during Cartesian fitting have correspond- 
ing numbers. The relaxation energy (AE,,,,,), root-mean square fit 
(RMS fit) and IC,, values calculated for the two peptides are 
shown below. 
Fig. 8. Superposition of the two isomeric tripeptides (D-Lys isomer, 
blue, and L-Lys isomer, red), with s-fluoxetine, yellow. These struc- 
tures have been “relaxed” by energy minimization after Cartesian 
fitting. The greatest deviation of fit is observable at the positive 
polarizable region of the pharmacophore. The nitro en-nitrogen 
distancedor the D-Lys tripeptide is measured at 3.13 1 , compared 
to 4.14 A, for the L-Lys tripeptide. 
conformation of s-fluoxetine was determined by the grid 
scan procedure, calculating molecular energies at 30” 
intervals about all sp”-sp” bonds. The resulting structure 
is shown in Figure 6, with the propanamine side chain 
forming a weak intramolecular hydrogen bond between 
the phenoxy oxygen and amine nitrogen atoms. It was 
this conformation which gave the best fit for the two 
isomcric tripeptides. 
The serotonin reuptake pharmacophore was modeled 
by fluoxetine, which can be represented by two 
hydrophobic (aromatic) regions and one positive ioniz- 
able region. As shown in Figure 7, seven atoms from 
each molecule were selected to represent these three 
regions of the pharmacophore. The fluoxetine mol- 
ecule was frozen to its low energy conformation and 
equivalent atoms from each molecule were then con- 
strained to the same space. As a result, each tripeptide 
was forced to adapt to that of the fluoxetine pharma- 
cophore model.As a measure of the tripeptide’s degree 
of similarity to the fluoxetine pharmacophore, a ‘relax- 
ation energy’ (AErclax ) and root-mean square deviation 
of fit for the two peptide molecules were calculated 
and are tabulated along with measured ICs,, values in 
Figure 7.The relaxation energy was defined by the dif- 
ference in energy values between the best-fit and the 
fully minimized structures. The root-mean square devi- 
ation of fit is defined in this case as the root-mean 
square distance between the seven atoms of fluoxetine 
and each of the two tripeptides. Figure 8 shows the 
best-fit superposition of the three molecules, after each 
has been energy minimized. 
Based on these valuey, the above procedure was able 
account for the difference in activity between the two 
tripeptides, [I] and [II]. The lower AErells calculated for 
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the U-Lys peptide, [I], is in agreement with the observed 
data, suggesting that this isomer can more readily adapt 
and bind to a serotonin reuptake active site than the L-Lys 
isomer, [II].The root-mean square deviation of fit values 
appear to be less sensitive, but are still in agreement with 
the observed activity data. 
The two tripeptides [I] and [II] were selected as examples 
for this exercise because they would be expected to differ 
only in their three-dimensional structures. As a conse- 
quence, other variables that could influence binding 
would be eliminated. If our pharmacophore model was 
accurate enough to account for all the molecular features 
that were representative of the entire peptide library, we 
would expect a trend of AE relax and root-mean square 
deviation of fit proportional to inhibitory activity. This 
does indeed appear to be the case, at least in the two 
examples tested. 
Significance 
We have shown here that a 10 000 tripeptide cas- 
sette library can be screened as mixtures of 
compounds, allowing the identification of sero- 
tonin and dopamine reuptake inhibitors with 
respectable inhibitory activity. The peptides 
identified in this study had IC,, values ranging 
from 3 PM for inhibition of serotonin reuptake 
to less than 1 ~.LM for inhibition of dopamine 
reuptake. Moreover, two of the peptides identi- 
fied here, peptides [I] and [II], have pharma- 
cophore features (namely, hydrophobicity and 
polarizability) similar to that of fluoxetine, 
which is known to be a selective and potent 
serotonin reuptake inhibitor. We conclude that 
peptide libraries will be useful in defining the 
important elements of a pharmacophore similar 
to active small non-peptide molecules such as 
fluoxetine. Because peptide libraries are more 
cost-effective to synthesize and are robust in 
spatial diversity, we suggest that this approach 
will be useful to ‘jump-start’ programs that aim 
to investigate structure-activity relationships. 
Materials and methods 
Molecular modeling 
The construction, energy minimization and display of all mole- 
cules were performed with Molecular Simulations Incorporated 
(MSI) molecular modeling package QUANTA/CHARMm, 
version 4.0, on a Silicon Graphics Indigo 2 workstation.The 
Cartesian forcing algorithm within the molecular similarity 
module was used to determine the degree of similarity or best- 
fit. Setup parameters that were used in these calculations were a 
15.0 A non-bonded cutoff distance, a 4.0 dielectric constant, 
and a 0.1 A rms force for determining energy convergence. 
Preparation of peptide library 
Peptide synthesis 
t-Boc-strategy with diisopropylcarbodiimide/hydroxybenzo- 
triazole (DIC/HOBT) activated esters was employed using 
RAMPS apparatus (DuPont) and a MBHA resin (Advanced 
Chem Tech) to generate carboxy-terminally amidated pep- 
tides. Boc-amino acids used in syntheses were D-Ala, ~-Asp 
(OBzl), D-Glu (OBzl), Phe, D-Phe, L-His (Born), L-Ile, L-Lys 
@cl-Z), D-Lys (2c1-z), D-LeU, L-Met, D-Asn, L-pro, D-Pro, 
L-Gln, L-Arg (Tos), L-Ser (Bzl), D-val, L-Trp, D-Trp, L-Tyr 
(2Br-Z) and D-Tyr (2,6Cl-Z). 
HF cleavage 
The peptide amides were removed from the resin and side-chain 
deprotected in HFlp-thiocresol/m-creso1(90:5:5) at 0°C for 60 
min using a multiple peptide cleavage apparatus (multiple peptide 
systems). The HF was vacuum-distilled and the peptides were 
precipitated with 50 ml of diethylether.After collection by filtra- 
tion, the peptides were washed extensively with diethylether, sol- 
ubilized in aqueous 50% acetic acid containing 30% acetonitrile, 
concentrated by distillation and then lyophilized. The recovered 
peptides were weighed and redisolved in aqueous 
acetonitrile/acetic acid to prepared lyophilized aliquots.The final 
31 purified tripeptides were prepared in a similar manner. 
Dopamine and serotonin reuptake assays 
Serotonin uptake assay 
Rat basophil leukemia (RBL) cells were trypsinized, counted 
and plated at a density of 1 x lo5 cells per 0.5 ml of growth 
medium in 24-well plates. For the uptake assay, cells were 
washed with uptake buffer (25 mM Hepes, pH 7.4/125 mM 
NaC1/4.8 mM KCli1.2 mM KH,P0,/1.3 mM CaC12/1.2 
mM MgS0,/5.6 mM glucose/l mM sodium ascorbate/lO 
mM pargyline) and preincubated with the tripeptides or other 
antagonists for 10 min at 37 “C. Uptake was initiated by the 
addition of 3H-serotonin for 15 min at 37 “C followed by three 
washes with ice-cold uptake buffer on ice. Cells were solubil- 
ized in 0.5 N NaOH and the amount of radioactivity was 
determined by liquid scintillation spectrometry, 
Dopamine uptake assay 
CVSVDAT cells (CV-1 cells stab111 transfected with dopamine 
transporter (DAT) driven by the SV40 promoter) were plated 
as above.The uptake assay was performed as above, except that 
3H-dopamine was incubated with cells for 10 min and the 
uptake was terminated by the additon of 0.25 ml of 1 mM 
dopamine followed by three washes with ice-cold uptake 
buffer on ice. Cells were solubilized with 0.5% Triton X-100 
and the amount of radioactivity was determined by liquid 
scintillation spectroscopy. 
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